Our solution ensures that companies like Pfizer not only maintain complete compliance, but are able to minimize business disruptions when new mandates rollout.
ATLANTA, GA (PRWEB) September 29, 2015
Invoiceware International, the leader in Latin American electronic invoicing and fiscal reporting, today announced that it has been selected by Pfizer for compliance support in Uruguay. Pfizer, a global leader in healthcare and pharmaceutical manufacturing, selected Invoiceware International to manage requirements mandated by the Uruguayan government spanning e-invoicing and daily reporting.
Invoiceware International has become the healthcare and pharmaceutical industry’s preferred partner in Latin America by reducing costs and the need for dedicated IT resources for dozens of healthcare and pharmaceutical manufacturers, including Medtronic, the world's largest standalone medical technology development company, and Qiagen, a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. Pfizer knew it needed a knowledgeable compliance partner to take on Uruguay’s comprehensive list of requirements and end-to-end certification process. The pharmaceutical leader selected Invoiceware International because of its complete end-to-end solution, which effectively manages changing regulations and eliminates the burden of addressing SAP modifications internally. Invoiceware International offers the only solution that enables the full automation of sending invoices in combination with the submission of daily fiscal reports required by the government in Uruguay, while also providing industry expertise to facilitate the initial certification process in Uruguay.
In July 2015, Uruguay’s DGI announced expanded deadlines for electronic invoicing based on company revenue. This latest mandate represents a more structured approach for Uruguay. Previously, the DGI would send a personal letter to companies mandating each to go live in approximately 6 months. For more information about Uruguay’s DGI requirements, click here.
“In Latin America, the governments have very stringent laws in the pharmaceutical industry, severely penalizing companies who fail to maintain compliance with processes like Uruguay’s e-invoicing and reporting requirements,” said Scott Lewin, President & CEO, Invoiceware International. “Our solution ensures that companies like Pfizer not only maintain complete compliance, but are able to minimize business disruptions when new mandates rollout. We fully support processes in Uruguay at a fixed cost, so that our clients can eliminate constant internal SAP ERP changes.”
About Invoiceware International
Invoiceware International is the leader in Latin American electronic invoicing and fiscal reporting, providing solutions and services that reduce the risk and cost of maintaining compliance across the region for the world’s largest companies, including Philips, Kellogg, DuPont and Siemens. Its proprietary Compliance Network, a hybrid cloud platform, delivers financial and supply chain managers the regulatory processes that they need while eliminating ERP configurations and customizations for IT staff. A single connection to the network simplifies the mandates, implementation and ongoing change management associated with regulations in Latin America, including Brazil Nota Fiscal, Mexico CFDI, Argentina AFIP, Chilean DTE, Uruguay, Peru and Ecuador. Learn more at Invoicewareint.com and by following @InvoicewareInt.
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. To learn more, please visit us at http://www.pfizer.com.